6J04

Crystal structure of full length human LC3B delta G120 mutant (2_125)

6J04 の概要

• エントリーDOI: 10.2210/pdb6j04/pdb
• 分子名称: Microtubule-associated proteins 1A/1B light chain 3B, SULFATE ION (3 entities in total)
• 機能のキーワード: lc3b, microtubule-associated protein light chain-3, autophage, protein binding
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 58507.45

構造登録者

Ding, Y.,Lu, B.X.,Wang, Z.Y. (登録日: 2018-12-21, 公開日: 2019-11-06, 最終更新日: 2023-11-22)

主引用文献

Li, Z.Y.,Wang, C.,Wang, Z.Y.,Zhu, C.G.,Li, J.,Sha, T.,Ma, L.X.,Gao, C.,Yang, Y.,Sun, Y.M.,Wang, J.,Sun, X.L.,Lu, C.Q.,Difiglia, M.,Mein, Y.,Ding, C.,Luo, S.Q.,Dang, Y.J.,Ding, Y.,Fei, Y.Y.,Lu, B.X.
Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds
Nature, 575:203-209, 2019

PubMed Abstract: Accumulation of mutant proteins is a major cause of many diseases (collectively called proteopathies), and lowering the level of these proteins can be useful for treatment of these diseases. We hypothesized that compounds that interact with both the autophagosome protein microtubule-associated protein 1A/1B light chain 3 (LC3) and the disease-causing protein may target the latter for autophagic clearance. Mutant huntingtin protein (mHTT) contains an expanded polyglutamine (polyQ) tract and causes Huntington's disease, an incurable neurodegenerative disorder. Here, using small-molecule-microarray-based screening, we identified four compounds that interact with both LC3 and mHTT, but not with the wild-type HTT protein. Some of these compounds targeted mHTT to autophagosomes, reduced mHTT levels in an allele-selective manner, and rescued disease-relevant phenotypes in cells and in vivo in fly and mouse models of Huntington's disease. We further show that these compounds interact with the expanded polyQ stretch and could lower the level of mutant ataxin-3 (ATXN3), another disease-causing protein with an expanded polyQ tract. This study presents candidate compounds for lowering mHTT and potentially other disease-causing proteins with polyQ expansions, demonstrating the concept of lowering levels of disease-causing proteins using autophagosome-tethering compounds.

PubMed: 31666698
DOI: 10.1038/s41586-019-1722-1

実験手法

X-RAY DIFFRACTION (1.899 Å)